Shopping Cart
- Remove All
- Your shopping cart is currently empty
NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $483 | In Stock | |
10 mg | $692 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,970 | In Stock |
Description | NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia. |
In vivo | Two structurally distinct NLRP3 inhibitors, NT-0249 and NT-0796, were able to reverse obesity in a mouse model of diet-induced obesity (DIO), and DIO-driven hypothalamic glial fibrillary acidic protein (GFAP) expression could be blocked by administration of NT-0249 or NT-0796. [1] |
Alias | NT0249 |
Molecular Weight | 481.54 |
Formula | C22H28N5NaO4S |
Cas No. | 2763617-39-4 |
Smiles | [N-](C(NS(N(C[C@@H]1CCCO1)C2=CN(C)N=C2)(=O)=O)=O)C3=C4C(=CC5=C3CCC5)CCC4.[Na+] |
Relative Density. | no data available |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.